ClinicalTrials.govpublic full text
Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
hematologic malignancies, cytomegalovirus (cmv) reactivation, leflunomide, haplo-hsct, haploidentical, hematopoietic stem cell transplant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805215
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.